Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
173.53-1.27 (-0.73%)
At close: 4:00 PM EDT

172.00 -1.53 (-0.88%)
Pre-Market: 4:00 AM EDT

People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close174.80
Bid172.00 x 400
Ask178.98 x 100
Day's Range172.83 - 174.42
52wk Range131.43 - 176.85
1y Target EstN/A
Market Cap129.86B
P/E Ratio (ttm)17.76
Avg Vol (3m)2,847,721
Dividend & Yield4.00 (2.29%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire17 minutes ago

    Amgen Announces Top-Line Results From Phase 3 KYPROLIS® (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients

    THOUSAND OAKS, Calif., Sept. 27, 2016 /PRNewswire/ -- Amgen (AMGN) today announced top-line results of the Phase 3 CLARION trial, which evaluated an investigational regimen of KYPROLIS® (carfilzomib), melphalan and prednisone (KMP) versus Velcade® (bortezomib), melphalan and prednisone (VMP) for 54 weeks in patients with newly diagnosed multiple myeloma who were ineligible for hematopoietic stem-cell transplant. Overall, the adverse events in the KMP arm were consistent with the known safety profile of KYPROLIS. The incidence of Grade 3 or higher adverse events was 74.7 percent in the KMP arm and 76.2 percent in the VMP arm.

  • PR Newswire11 hours ago

    Amgen Opens Nomination Process For LabCentral Residency

    CAMBRIDGE, Mass., Sept. 26, 2016 /PRNewswire/ -- Amgen (AMGN) today announced that the nomination process to submit proposals to receive an Amgen-sponsored LabCentral Golden Ticket is open for interested life-sciences and biotech startup companies in Massachusetts. LabCentral is an innovative, shared laboratory space designed as a launch pad for premier high-impact life-sciences and biotech startups. As one of LabCentral's platinum sponsors, Amgen can nominate up to two early-stage companies each year to take up residence in LabCentral's Kendall Square facilities in Cambridge, Mass.

  • TheStreet.com12 hours ago

    Wall Street Sells Off on Worries Over Clinton-Trump Showdown

    Stocks end Monday's session sharply lower as Wall Street grows restless ahead of the first presidential debate.